Amplifold
Amplifold develops the next generation of rapid tests using DNA origami nanotechnology – tiny structures made from DNA that we design to detect specific molecules with extremely high accuracy.
Amplifold has raised €5.0M across 1 funding round from 5 investors, most recently a Seed round in Dec 2025. Based in Munich, Germany; active in Healthtech. Data as of 28 Oct 2026.
Munich, Germanywww.amplifold.cm ↗
Total raised
€5.0M
€5,000,000
Funding rounds
1
Investors
5
distinct backers
Active since
2025-12
latest 2025-12
Funding by year
EUR raised per yearAmplifold — funding by year — interactive chart.
Data table
| Amplifold — funding by year | |
|---|---|
| 2025 | €5.0M |
Signals
High confidenceRaise-next likelihood57
base rate 44% for Seed
- ▲ In typical raise window
- ▼ Low backer re-investment
Timing: in window vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2025-12-10 | Seed | €5.0M | b2venture,Bayern Kapital,Becker Ventures,Matterwave Ventures,xista science ventures | View deal → |
Related news
Similar companies
same sector or country- Delivery Hero€7.1BGermany · E-commerce
- Enpal€4.6BGermany · Cleantech
- Auxmoney€3.5BGermany · Fintech
- Helsing€2.9BGermany · AI
- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
Global coverage: FundingData